Finance

Lists
Why is 300562 down 2,46%?
Dive Deeper
300562:SHE
Guangdong Transtek Medicl Elctrncs CoLtd
13,08 CN¥
-2,46%
(-0,33) 1D
16 հոկ, 15:04:58 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300562...
Open
13,67 CN¥
High
13,77 CN¥
Low
12,94 CN¥
Mkt. cap
2,86 մլրդ
Avg. vol.
16,51 մլն
Volume
8,14 մլն
Dividend
1,99%
Quarterly dividend
0,07 CN¥
Ex-dividend date
15 հոկ, 2026 թ.
P/E ratio
28,64
52-wk high
19,54 CN¥
52-wk low
11,32 CN¥
EPS
0,46 CN¥
Shares outstanding
218,93 մլն
No. of employees
1 հզր
Open
13,67 CN¥
High
13,77 CN¥
Low
12,94 CN¥
Mkt. cap
2,86 մլրդ
Avg. vol.
16,51 մլն
Volume
8,14 մլն
Dividend
1,99%
Quarterly dividend
0,07 CN¥
Ex-dividend date
15 հոկ, 2026 թ.
P/E ratio
28,64
52-wk high
19,54 CN¥
52-wk low
11,32 CN¥
EPS
0,46 CN¥
Shares outstanding
218,93 մլն
No. of employees
1 հզր
News stories
From web sources and news partners
Profile
Transtek Medical, commonly known as Lifesense, fully referred to as Guangdong Transtek Medical Electronics Co., Ltd., is a Chinese wearable device maker that also focuses on the field of mobile health. The company was founded by Weichao Pan in 2002, with its main products being home medical and health electronics, such as scales, smart bracelets and blood pressure monitors. According to IDC, the company shipped one million units of wearables in the second quarter of 2016, ranking fifth in the global wearable devices market, coming in behind Fitbit, Apple and Garmin. Transtek's IPO application was approved by the CSRC in October 2016. On November 16, it landed on the Shenzhen Stock Exchange with the ticker symbol "300562.SZ". Wikipedia
About Guangdong Transtek Medicl Elctrncs CoLtd
CEO-
Employees1,09 հզր
Founded18 հլս, 2002 թ.
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
235,76 մլն
229,08 մլն
283,74 մլն
250,69 մլն
Cost of goods sold
149,14 մլն
152,94 մլն
176,58 մլն
166,11 մլն
Cost of revenue
149,14 մլն
152,94 մլն
176,58 մլն
166,11 մլն
Research and development expenses
20,36 մլն
24,79 մլն
26,69 մլն
23,33 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
41,57 մլն
26,45 մլն
41,12 մլն
21,85 մլն
Operating expense
58,96 մլն
52,61 մլն
71,19 մլն
48,25 մլն
Total operating expenses
208,10 մլն
205,55 մլն
247,78 մլն
214,35 մլն
Operating income
27,66 մլն
23,53 մլն
35,96 մլն
36,34 մլն
Other non operating income
-3,39 մլն
2,22 մլն
-4,58 մլն
3,96 մլն
EBT including unusual items
23,63 մլն
16,59 մլն
32,82 մլն
31,28 մլն
EBT excluding unusual items
25,70 մլն
24,73 մլն
31,68 մլն
34,21 մլն
Income tax expense
118,51 հզր
1,08 մլն
931,10 հզր
3,84 մլն
Effective tax rate
0,50%
6,54%
2,84%
12,27%
Other operating expenses
-1,92 մլն
3,87 մլն
1,19 մլն
2,80 մլն
Net income
23,39 մլն
16,32 մլն
32,07 մլն
27,96 մլն
Net profit margin
9,92%
7,12%
11,30%
11,15%
Earnings per share
-
-
-
-
Interest and investment income
3,39 մլն
2,85 մլն
330,33 հզր
3,10 մլն
Interest expense
-1,40 մլն
-
-37,02 հզր
-57,71 հզր
Net interest expenses
1,99 մլն
2,85 մլն
293,32 հզր
3,05 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
32,45 մլն
28,29 մլն
40,73 մլն
41,00 մլն
Gain or loss from assets sale
-150,13 հզր
26,11 հզր
-
-1,36 մլն
AI content may include mistakes. Learn more
Google Apps